72% of Florida Business Leaders Say Biotech is Florida's Next Innovation Boom, According to Foley Flash Poll
05 May 2008
Despite Importance of Intellectual Property in Biotech Growth, One in Three Still Classify Their IP Strategy as “Defensive/Reactive”
A flash poll of business leaders at a recent Foley conference revealed insights into where the state is likely headed in terms of business growth – with 72 percent indicating that biotech will see the most significant growth in the next two years. However, despite the role a strong Intellectual Property (IP) strategy will play in the growth of these areas, 36 percent of respondents characterized their company’s approach to IP as “defensive/reactive.”
Click here to download the press release
Related Insights
22 April 2025
Health Care Law Today
Skilled Nursing Facilities: CMS Extends Medicare Revalidation Deadline
On April 17, 2025, the Centers for Medicare and Medicaid Services (CMS) announced another extension of the deadline by which skilled nursing facilities (SNFs) must revalidate their Medicare enrollments.
21 August 2025
Events
6th Clinical Trial Agreements Summit
Foley partners Monica Chmielewski, vice chair of the firm’s Health Care Practice Group, Kyle Faget, and Nate Beaver, co-chairs of the firm’s Medical Devices Area of Focus, are speaking at Dynamic Global Events’ 6th Clinical Trial Agreements (CTA) Summit on August 21-22.
21 April 2025
Health Care Law Today
Prescription Drugs: Executive Order Aims to Lower Prices
On April 15, 2025, President Trump signed an executive order (EO) with the aim of reducing the cost of prescription drugs.